Cargando…

Interleukin-24 therapy- a potential new strategy against liver fibrosis

Detalles Bibliográficos
Autores principales: Petrescu, Anca D., DeMorrow, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921474/
https://www.ncbi.nlm.nih.gov/pubmed/33639397
http://dx.doi.org/10.1016/j.ebiom.2021.103245
_version_ 1783658477467467776
author Petrescu, Anca D.
DeMorrow, Sharon
author_facet Petrescu, Anca D.
DeMorrow, Sharon
author_sort Petrescu, Anca D.
collection PubMed
description
format Online
Article
Text
id pubmed-7921474
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-79214742021-03-12 Interleukin-24 therapy- a potential new strategy against liver fibrosis Petrescu, Anca D. DeMorrow, Sharon EBioMedicine Commentary Elsevier 2021-02-24 /pmc/articles/PMC7921474/ /pubmed/33639397 http://dx.doi.org/10.1016/j.ebiom.2021.103245 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Petrescu, Anca D.
DeMorrow, Sharon
Interleukin-24 therapy- a potential new strategy against liver fibrosis
title Interleukin-24 therapy- a potential new strategy against liver fibrosis
title_full Interleukin-24 therapy- a potential new strategy against liver fibrosis
title_fullStr Interleukin-24 therapy- a potential new strategy against liver fibrosis
title_full_unstemmed Interleukin-24 therapy- a potential new strategy against liver fibrosis
title_short Interleukin-24 therapy- a potential new strategy against liver fibrosis
title_sort interleukin-24 therapy- a potential new strategy against liver fibrosis
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921474/
https://www.ncbi.nlm.nih.gov/pubmed/33639397
http://dx.doi.org/10.1016/j.ebiom.2021.103245
work_keys_str_mv AT petrescuancad interleukin24therapyapotentialnewstrategyagainstliverfibrosis
AT demorrowsharon interleukin24therapyapotentialnewstrategyagainstliverfibrosis